29 July 2024
Cranswick plc (“Cranswick” or “the Company” or “the Group”) First quarter trading statement Cranswick, a leading UK food producer, today provides an update on trading for…
Concurrent Technologies Plc (the “Company” or the “Group”) Concurrent Technologies Launches a New Product Concurrent Technologies PLC (AIM: CNC), a designer and manufacturer of…
Statement: Zantac (ranitidine) litigation – Kimbrow case GSK plc (LSE/NYSE: GSK) has reached a confidential settlement with Ronald Kimbrow resolving the case he filed…
STRONG TRADING IN THE UNDERLYING PORTFOLIO CONTINUES TO DRIVE GROWTH London, 29 July 2024: HgCapital Trust plc (‘HgT’) today announces a preliminary trading update for…
INTERIM RESULTS ANNOUNCEMENT Results for the six months ended 30 June 2024 The full Interim Report for the six months ended 30 June 2024…
Fixed-duration Calquence plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukaemia in AMPLIFY Phase III trial Favourable trend in overall survival…
29 July 2024 Dotdigital Group plc (“Dotdigital”, the “Company”, or the “Group”) Trading Update A year of financial and strategic progress Dotdigital Group plc (AIM: DOTD),…
Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announces: Key Highlights Revenue €17,823 millionNet revenue (beia) 6.0% organic growth; per hectolitre 4.3%Beer volume organic growth 2.1%; Heineken®…